Showing results (121-130 of 274) with videos related to
Sort By:
Pageof 28
Proceedings of the National Academy of Sciences of the United States of America|June 10, 1997
Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activityH L Tai, E Y Krynetski, E G Schuetz, et al.Cancer Research|November 1, 1980
Phase I clinical and pharmacokinetic study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide in children with cancerG Rivera, W E Evans, G V Dahl, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1995
Liver volume as a determinant of drug clearance in children and adolescentsD J Murry, W R Crom, W E Reddick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Effect of hydration on methotrexate plasma concentrations in children with acute lymphocytic leukemiaM L Christensen, G K Rivera, W R Crom, et al.Clinical Pharmacology and Therapeutics|January 1, 1994
Thiopurine methyltransferase activity in American white subjects and black subjectsH L McLeod, J S Lin, E P Scott, et al.Clinical Pharmacology and Therapeutics|August 1, 1991
Age-related differences in hepatic drug clearance in children: studies with lorazepam and antipyrineW R Crom, M V Relling, M L Christensen, et al.Clinical Pharmacology and Therapeutics|May 1, 1983
Bleomycin disposition in children with cancerG C Yee, W R Crom, F H Lee, et al.Molecular Pharmacology|February 13, 2001
A novel protein complex distinct from mismatch repair binds thioguanylated DNAE Y Krynetski, N F Krynetskaia, A E Gallo, et al.Clinical Pharmacology and Therapeutics|May 1, 1996
Hepatic drug clearance in patients with mild cystic fibrosisG L Kearns, W R Crom, K H Karlson, et al.Clinical Pharmacology and Therapeutics|September 6, 2012
Pharmacogenomics and individualized medicine: translating science into practiceK R Crews, J K Hicks, C-H Pui, et al.Pageof 28